Picture of Neodynamics AB (publ) logo

NEOD — Neodynamics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: NeoDynamics Receives Regulatory Approval For New Breast Cancer Biopsy System

Oct 29 (Reuters) - NeoDynamics AB  NEOD.TE :
    * NEODYNAMICS RECEIVES REGULATORY APPROVAL FOR NEW BREAST
CANCER
BIOPSY SYSTEM
    * CONFIRMATION THAT INTERTEK HAS ACCEPTED NEW IMPROVED
VERSION AS
AN UPDATE TO ALREADY EU APPROVED SYSTEM USED IN CLINICAL TRIALS
IN GERMANY, UK AND SWEDEN, ELIMINATES UNCERTAINTY AND
SIGNIFICANTLY SHORTENS TIME TO MARKET

Source text for Eikon:  ID:nWkrbxBYnR 
Further company coverage:  NEOD.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Neodynamics AB (publ)

See all news